Annual Net Income
-$37.34 M
+$3.96 M+9.59%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual net profit is -$37.34 million, with the most recent change of +$3.96 million (+9.59%) on December 31, 2023.
- During the last 3 years, SLS annual net income has fallen by -$20.58 million (-122.83%).
- SLS annual net income is now -1452.60% below its all-time high of -$2.40 million, reached on December 31, 2006.
Performance
SLS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$7.11 M
+$362.00 K+4.85%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly net profit is -$7.11 million, with the most recent change of +$362.00 thousand (+4.85%) on September 30, 2024.
- Over the past year, SLS quarterly net income has increased by +$1.03 million (+12.64%).
- SLS quarterly net income is now -231.90% below its all-time high of $5.39 million, reached on June 30, 2016.
Performance
SLS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$32.28 M
+$2.16 M+6.27%
September 30, 2024
Summary
- As of February 8, 2025, SLS TTM net profit is -$32.28 million, with the most recent change of +$2.16 million (+6.27%) on September 30, 2024.
- Over the past year, SLS TTM net income has increased by +$5.06 million (+13.55%).
- SLS TTM net income is now -4114.10% below its all-time high of -$766.00 thousand, reached on December 31, 2006.
Performance
SLS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SLS Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.6% | +12.6% | +13.6% |
3 y3 years | -122.8% | +19.6% | +10.5% |
5 y5 years | -35.0% | +19.6% | +10.5% |
SLS Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -80.4% | +9.6% | -7.7% | +57.5% | -56.0% | +21.8% |
5 y | 5-year | -122.8% | +9.6% | -195.8% | +57.5% | -115.0% | +21.8% |
alltime | all time | -1452.6% | +51.3% | -231.9% | +85.3% | -4114.1% | +59.8% |
SELLAS Life Sciences Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$7.11 M(-4.8%) | -$32.28 M(-6.3%) |
Jun 2024 | - | -$7.47 M(-21.9%) | -$34.44 M(-3.8%) |
Mar 2024 | - | -$9.57 M(+17.6%) | -$35.81 M(-4.1%) |
Dec 2023 | -$37.34 M(-9.6%) | -$8.14 M(-12.2%) | -$37.34 M(-2.6%) |
Sep 2023 | - | -$9.27 M(+4.8%) | -$38.33 M(+6.2%) |
Jun 2023 | - | -$8.84 M(-20.3%) | -$36.08 M(+1.2%) |
Mar 2023 | - | -$11.10 M(+21.7%) | -$35.65 M(-13.7%) |
Dec 2022 | -$41.30 M(+99.5%) | -$9.12 M(+29.9%) | -$41.30 M(+6.5%) |
Sep 2022 | - | -$7.02 M(-16.5%) | -$38.78 M(-0.2%) |
Jun 2022 | - | -$8.41 M(-49.7%) | -$38.84 M(+10.8%) |
Mar 2022 | - | -$16.74 M(+153.8%) | -$35.04 M(+69.3%) |
Dec 2021 | -$20.70 M(+23.5%) | -$6.60 M(-6.9%) | -$20.70 M(+16.2%) |
Sep 2021 | - | -$7.08 M(+53.6%) | -$17.82 M(+17.2%) |
Jun 2021 | - | -$4.61 M(+92.0%) | -$15.21 M(+1.3%) |
Mar 2021 | - | -$2.40 M(-35.3%) | -$15.02 M(-10.4%) |
Dec 2020 | -$16.76 M(-13.1%) | -$3.72 M(-16.9%) | -$16.76 M(-18.1%) |
Sep 2020 | - | -$4.47 M(+1.1%) | -$20.46 M(+1.3%) |
Jun 2020 | - | -$4.42 M(+6.8%) | -$20.19 M(+6.8%) |
Mar 2020 | - | -$4.14 M(-44.2%) | -$18.90 M(-2.0%) |
Dec 2019 | -$19.29 M(-30.3%) | -$7.42 M(+76.6%) | -$19.29 M(-23.4%) |
Sep 2019 | - | -$4.20 M(+34.1%) | -$25.20 M(+18.4%) |
Jun 2019 | - | -$3.13 M(-30.9%) | -$21.28 M(-12.1%) |
Mar 2019 | - | -$4.54 M(-65.9%) | -$24.21 M(-12.5%) |
Dec 2018 | -$27.67 M(+16.5%) | -$13.32 M(+4494.1%) | -$27.67 M(+132.4%) |
Sep 2018 | - | -$290.00 K(-95.2%) | -$11.90 M(-32.7%) |
Jun 2018 | - | -$6.06 M(-24.2%) | -$17.69 M(+0.8%) |
Mar 2018 | - | -$8.00 M(-427.3%) | -$17.54 M(+24.0%) |
Dec 2017 | -$23.75 M(+34.3%) | $2.44 M(-140.2%) | -$14.15 M(-12.9%) |
Sep 2017 | - | -$6.08 M(+2.7%) | -$16.24 M(-5.0%) |
Jun 2017 | - | -$5.91 M(+28.5%) | -$17.09 M(+195.2%) |
Mar 2017 | - | -$4.60 M(-1407.1%) | -$5.79 M(-67.3%) |
Dec 2016 | -$17.68 M(-72.3%) | $352.00 K(-105.1%) | -$17.68 M(-53.1%) |
Sep 2016 | - | -$6.93 M(-228.6%) | -$37.71 M(-22.7%) |
Jun 2016 | - | $5.39 M(-132.7%) | -$48.81 M(-30.1%) |
Mar 2016 | - | -$16.49 M(-16.2%) | -$69.86 M(+9.3%) |
Dec 2015 | -$63.90 M | -$19.68 M(+9.2%) | -$63.90 M(+22.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2015 | - | -$18.03 M(+15.1%) | -$52.18 M(+29.4%) |
Jun 2015 | - | -$15.66 M(+48.6%) | -$40.33 M(-9.6%) |
Mar 2015 | - | -$10.54 M(+32.4%) | -$44.61 M(+21.9%) |
Dec 2014 | -$36.61 M(-52.3%) | -$7.96 M(+28.9%) | -$36.61 M(-52.6%) |
Sep 2014 | - | -$6.17 M(-69.0%) | -$77.15 M(-3.9%) |
Jun 2014 | - | -$19.94 M(+686.3%) | -$80.27 M(+14.8%) |
Mar 2014 | - | -$2.54 M(-94.8%) | -$69.92 M(-8.8%) |
Dec 2013 | -$76.68 M(+119.3%) | -$48.50 M(+422.2%) | -$76.68 M(+140.2%) |
Sep 2013 | - | -$9.29 M(-3.2%) | -$31.93 M(+10.5%) |
Jun 2013 | - | -$9.60 M(+3.3%) | -$28.90 M(+48.2%) |
Mar 2013 | - | -$9.29 M(+147.7%) | -$19.50 M(-44.2%) |
Dec 2012 | -$34.97 M(+204.5%) | -$3.75 M(-40.1%) | -$34.97 M(+18.0%) |
Sep 2012 | - | -$6.26 M(+3094.4%) | -$29.63 M(+2.7%) |
Jun 2012 | - | -$196.00 K(-99.2%) | -$28.84 M(-11.0%) |
Mar 2012 | - | -$24.76 M(-1658.3%) | -$32.40 M(+182.2%) |
Dec 2011 | -$11.48 M(-4.2%) | $1.59 M(-129.0%) | -$11.48 M(-23.0%) |
Sep 2011 | - | -$5.47 M(+45.8%) | -$14.90 M(+9.9%) |
Jun 2011 | - | -$3.75 M(-2.3%) | -$13.56 M(+13.5%) |
Mar 2011 | - | -$3.84 M(+109.8%) | -$11.95 M(-0.4%) |
Dec 2010 | -$11.99 M(-34.8%) | -$1.83 M(-55.7%) | -$11.99 M(-26.5%) |
Sep 2010 | - | -$4.13 M(+93.1%) | -$16.31 M(+7.6%) |
Jun 2010 | - | -$2.14 M(-44.9%) | -$15.16 M(-16.2%) |
Mar 2010 | - | -$3.89 M(-36.8%) | -$18.10 M(-1.6%) |
Dec 2009 | -$18.39 M(+27.9%) | -$6.15 M(+105.8%) | -$18.39 M(+13.2%) |
Sep 2009 | - | -$2.99 M(-41.2%) | -$16.24 M(-2.5%) |
Jun 2009 | - | -$5.08 M(+21.8%) | -$16.66 M(+4.8%) |
Mar 2009 | - | -$4.17 M(+4.2%) | -$15.90 M(+10.6%) |
Dec 2008 | -$14.37 M(+30.8%) | -$4.00 M(+17.4%) | -$14.37 M(+10.6%) |
Sep 2008 | - | -$3.41 M(-21.1%) | -$12.99 M(+10.3%) |
Jun 2008 | - | -$4.32 M(+63.2%) | -$11.78 M(-3.6%) |
Mar 2008 | - | -$2.65 M(+0.9%) | -$12.22 M(+11.2%) |
Dec 2007 | -$10.99 M(+357.0%) | -$2.62 M(+19.4%) | -$10.99 M(+20.3%) |
Sep 2007 | - | -$2.20 M(-53.9%) | -$9.13 M(+31.7%) |
Jun 2007 | - | -$4.76 M(+237.0%) | -$6.94 M(+218.5%) |
Mar 2007 | - | -$1.41 M(+84.3%) | -$2.18 M(+184.3%) |
Dec 2006 | -$2.40 M | -$766.00 K | -$766.00 K |
FAQ
- What is SELLAS Life Sciences annual net profit?
- What is the all time high annual net income for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual net income year-on-year change?
- What is SELLAS Life Sciences quarterly net profit?
- What is the all time high quarterly net income for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly net income year-on-year change?
- What is SELLAS Life Sciences TTM net profit?
- What is the all time high TTM net income for SELLAS Life Sciences?
- What is SELLAS Life Sciences TTM net income year-on-year change?
What is SELLAS Life Sciences annual net profit?
The current annual net income of SLS is -$37.34 M
What is the all time high annual net income for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual net profit is -$2.40 M
What is SELLAS Life Sciences annual net income year-on-year change?
Over the past year, SLS annual net profit has changed by +$3.96 M (+9.59%)
What is SELLAS Life Sciences quarterly net profit?
The current quarterly net income of SLS is -$7.11 M
What is the all time high quarterly net income for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly net profit is $5.39 M
What is SELLAS Life Sciences quarterly net income year-on-year change?
Over the past year, SLS quarterly net profit has changed by +$1.03 M (+12.64%)
What is SELLAS Life Sciences TTM net profit?
The current TTM net income of SLS is -$32.28 M
What is the all time high TTM net income for SELLAS Life Sciences?
SELLAS Life Sciences all-time high TTM net profit is -$766.00 K
What is SELLAS Life Sciences TTM net income year-on-year change?
Over the past year, SLS TTM net profit has changed by +$5.06 M (+13.55%)